Man Group plc
- SEC CIK
- 0001637460
- Latest filing
- Aug 14, 2026
TVTX holding history
Travere Therapeutics, Inc. in every 13F filed by Man Group plc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −7,356−100.0% | Sold out | Holders |
| Q1 2026 | 7,356 | $218.5K | <0.1% | +7,356 | New | Holders |
| Q4 2025 | 0 | $0 | 0.0% | −29,727−100.0% | Sold out | Holders |
| Q3 2025 | 29,727 | $710.5K | <0.1% | −109,317−78.6% | Reduced | Holders |
| Q2 2025 | 139,044 | $2.06M | <0.1% | +90,265+185.0% | Added | Holders |
| Q1 2025 | 48,779 | $874.1K | <0.1% | −39,462−44.7% | Reduced | Holders |
| Q4 2024 | 88,241 | $1.54M | <0.1% | +62,798+246.8% | Added | Holders |
| Q3 2024 | 25,443 | $355.9K | <0.1% | −73,219−74.2% | Reduced | Holders |
| Q2 2024 | 98,662 | $811.0K | <0.1% | −18,939−16.1% | Reduced | Holders |
| Q1 2024 | 117,601 | $906.7K | <0.1% | +117,601 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | – | Sold out | Holders |
| Q1 2023 | – | $416.1K | <0.1% | – | – | Holders |
| Q4 2022 | 21,300 | $447.9K | <0.1% | +2,800+15.1% | Added | Holders |
| Q3 2022 | 18,500 | $456.0K | <0.1% | +18,500 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −9,500−100.0% | Sold out | Holders |
| Q1 2022 | 9,500 | $245.0K | <0.1% | +9,500 | New | Holders |